» Articles » PMID: 37046073

In Vitro to in Vivo Extrapolation and High-content Imaging for Simultaneous Characterization of Chemically Induced Liver Steatosis and Markers of Hepatotoxicity

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2023 Apr 12
PMID 37046073
Authors
Affiliations
Soon will be listed here.
Abstract

Chemically induced steatosis is characterized by lipid accumulation associated with mitochondrial dysfunction, oxidative stress and nucleus distortion. New approach methods integrating in vitro and in silico models are needed to identify chemicals that may induce these cellular events as potential risk factors for steatosis and associated hepatotoxicity. In this study we used high-content imaging for the simultaneous quantification of four cellular markers as sentinels for hepatotoxicity and steatosis in chemically exposed human liver cells in vitro. Furthermore, we evaluated the results with a computational model for the extrapolation of human oral equivalent doses (OED). First, we tested 16 reference chemicals with known capacities to induce cellular alterations in nuclear morphology, lipid accumulation, mitochondrial membrane potential and oxidative stress. Then, using physiologically based pharmacokinetic modeling and reverse dosimetry, OEDs were extrapolated from data of any stimulated individual sentinel response. The extrapolated OEDs were confirmed to be within biologically relevant exposure ranges for the reference chemicals. Next, we tested 14 chemicals found in food, selected from thousands of putative chemicals on the basis of structure-based prediction for nuclear receptor activation. Amongst these, orotic acid had an extrapolated OED overlapping with realistic exposure ranges. Thus, we were able to characterize known steatosis-inducing chemicals as well as data-scarce food-related chemicals, amongst which we confirmed orotic acid to induce hepatotoxicity. This strategy addresses needs of next generation risk assessment and can be used as a first chemical prioritization hazard screening step in a tiered approach to identify chemical risk factors for steatosis and hepatotoxicity-associated events.

Citing Articles

A simple, reliable and easily generalizable cell-based assay for screening potential drugs that inhibit lipid accumulation.

Yang W, Pan Q, Li Q, Zhou S, Cao X Curr Res Toxicol. 2025; 8():100213.

PMID: 39834517 PMC: 11743863. DOI: 10.1016/j.crtox.2024.100213.


Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMs.

Lai Y, Ay M, Hospital C, Miller G, Sarkar S Environ Health Perspect. 2024; 132(9):94201.

PMID: 39230330 PMC: 11373422. DOI: 10.1289/EHP13120.


High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage.

Lai Y, Koelmel J, Walker D, Price E, Papazian S, Manz K Environ Sci Technol. 2024; 58(29):12784-12822.

PMID: 38984754 PMC: 11271014. DOI: 10.1021/acs.est.4c01156.

References
1.
Allard J, Bucher S, Massart J, Ferron P, Le Guillou D, Loyant R . Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2020; 37(2):151-175. PMC: 8012331. DOI: 10.1007/s10565-020-09537-1. View

2.
Allen T, Goodman J, Gutsell S, Russell P . Defining molecular initiating events in the adverse outcome pathway framework for risk assessment. Chem Res Toxicol. 2014; 27(12):2100-12. DOI: 10.1021/tx500345j. View

3.
Alnahdi A, John A, Raza H . Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid. Nutrients. 2019; 11(9). PMC: 6770774. DOI: 10.3390/nu11091979. View

4.
Andersson T, Kanebratt K, Kenna J . The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin Drug Metab Toxicol. 2012; 8(7):909-20. DOI: 10.1517/17425255.2012.685159. View

5.
Angrish M, McQueen C, Cohen-Hubal E, Bruno M, Ge Y, Chorley B . Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis. Toxicol Sci. 2017; 159(1):159-169. PMC: 8130650. DOI: 10.1093/toxsci/kfx121. View